<p>Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?</p>-Reference-Cited by-同舟云学术

Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?

Published:2020-09 Issue: Volume:Volume 13 Page:3243-3254
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Al-Ani Mena,Elemam Noha Mousaad^ORCID,Hundt Jennifer Elisabeth,Maghazachi Azzam A^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference139 articles.

1. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

2. The COVID‐19 epidemic

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin

4. GISAID Global Initiative on Sharing All Inﬂuenza Data. Phylogeny of SARS-like betacoronaviruses including novelcoronavirus (nCoV). Available from: https://nextstrain.org/groups/blab/sars-like-cov.

5. A novel coronavirus outbreak of global health concern

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical immunomodulatory activity of COVIDEX herbal product developed for supportive treatment of COVID-19 in Uganda;African Journal of Pharmacy and Pharmacology;2024-07-31

2. NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy;Pharmaceuticals;2024-01-23

3. The course of COVID-19 in a multiple sclerosis: a case report;Wiadomości Lekarskie;2024-01

4. A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments;Biomedicines;2023-09-08

5. Novel potential pharmacological applications of dimethyl fumarate—an overview and update;Frontiers in Pharmacology;2023-09-07